{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:43:56Z","timestamp":1793641436450,"version":"4.5.1"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.critrevonc.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:09:41Z","timestamp":1527754181000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["Cancer cachexia: Diagnosis, assessment, and treatment"],"prefix":"10.1016","volume":"127","author":[{"given":"Mohammadamin","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Keshavarz-Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2014.11.029","article-title":"Aerobic exercise training as therapy for cardiac and cancer cachexia","volume":"125","author":"Alves","year":"2015","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0015","first-page":"61","article-title":"Causes of death in cancer patients","volume":"6","author":"Ambrus","year":"1975","journal-title":"J. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib0020","doi-asserted-by":"crossref","first-page":"e102436","DOI":"10.1371\/journal.pone.0102436","article-title":"Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer","volume":"9","author":"Ando","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0025","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","article-title":"Possible role for tocilizumab, an anti\u2013interleukin-6 receptor antibody, in treating cancer cachexia","volume":"31","author":"Ando","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.biocel.2004.10.003","article-title":"Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia","volume":"37","author":"Argiles","year":"2005","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia","volume":"3","author":"Argiles","year":"2009","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argiles","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/CMAR.S7101","article-title":"Optimal management of cancer anorexia-cachexia syndrome","author":"Argiles","year":"2010","journal-title":"Cancer Manag Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13539-012-0067-5","article-title":"Are there any benefits of exercise training in cancer cachexia?","volume":"3","author":"Argiles","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4161\/cbt.12.11.18134","article-title":"Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia","volume":"12","author":"Asp","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0070","first-page":"713","article-title":"Beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia","volume":"38","author":"Aversa","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J. Gastrointest. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/082585970201800207","article-title":"Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature","volume":"18","author":"Bagshaw","year":"2002","journal-title":"J. Palliat. Care"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.critrevonc.2014.02.005","article-title":"Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review","volume":"91","author":"Balstad","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0090","first-page":"67","volume":"vol. 16","author":"Barbat-Artigas","year":"2012"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cyto.2012.10.023","article-title":"Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients","volume":"61","author":"Batista","year":"2013","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0100","first-page":"257","article-title":"Comparison of a malnutrition screening tool with subjective global assessment in hospitalised patients with cancer--sensitivity and specificity","volume":"12","author":"Bauer","year":"2003","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0029-6465(22)01708-X","article-title":"Psychosocial aspects of nutritional support","volume":"18","author":"Bayer","year":"1983","journal-title":"Nurs. Clin. North Am."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0115","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.NCC.0000305684.51884.1f","article-title":"Reliability and validity of the functional living index-cancer in Turkish cancer patients","volume":"31","author":"Bektas","year":"2008","journal-title":"Cancer Nurs."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/bjc.1991.159","article-title":"Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss","volume":"63","author":"Belizario","year":"1991","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-4804(91)90002-4","article-title":"Decreased myofibrillar protein breakdown following treatment with clenbuterol","volume":"50","author":"Benson","year":"1991","journal-title":"J. Surg. Res."},{"issue":"23","key":"10.1016\/j.critrevonc.2018.05.006_bib0130","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1200\/JCO.2012.48.4147","article-title":"Assessment of tocilizumab in the treatment of cancer cachexia","volume":"31","author":"Berti","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12032-015-0497-y","article-title":"The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia","volume":"32","author":"Bilir","year":"2015","journal-title":"Med. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/annonc\/mdu178","article-title":"\u2019Pre-cachexia\u2019: a non-existing phenomenon in cancer?","volume":"25","author":"Blauwhoff-Buskermolen","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/SPC.0b013e32834c4a05","article-title":"Cachexia assessment tools","volume":"5","author":"Blum","year":"2011","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0150","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","article-title":"Validation of the consensus-definition for cancer cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA)","volume":"25","author":"Blum","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0155","first-page":"591","article-title":"Preoperative nutritional risk index to predict postoperative survival time in primary liver cancer patients","volume":"24","author":"Bo","year":"2015","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.1332","article-title":"Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients","volume":"93","author":"Bosaeus","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0165","first-page":"243","article-title":"Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care","volume":"54","author":"Bovio","year":"2008","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0170","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.clnu.2013.07.003","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Bozzetti","year":"2013","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clnu.2012.10.017","article-title":"Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature","volume":"32","author":"Bozzetti","year":"2013","journal-title":"Clin. Nutr"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0148607108325076","article-title":"Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group","volume":"33","author":"Bozzetti","year":"2009","journal-title":"JPEN J. Parenter. Enter. Nutr"},{"issue":"7-8","key":"10.1016\/j.critrevonc.2018.05.006_bib0185","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treat. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","article-title":"Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia\/cachexia: a double-blind, placebo-controlled study","volume":"21","author":"Bruera","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0195","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.critrevonc.2018.05.006_bib0200","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12032-016-0768-2","article-title":"Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer","volume":"33","author":"Bye","year":"2016","journal-title":"Med. Oncol."},{"issue":"21","key":"10.1016\/j.critrevonc.2018.05.006_bib0210","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"Cannabis In Cachexia Study, Group","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition - an ESPEN consensus statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1359105304044030","article-title":"Food and health: expanding the agenda for health psychology","volume":"9","author":"Chamberlain","year":"2004","journal-title":"J. Health Psychol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0225","first-page":"377","article-title":"The functional assessment of Anorexia\/Cachexia therapy (FAACT) appetite scale in veteran cancer patients","volume":"3","author":"Chang","year":"2005","journal-title":"J. Support Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jamda.2010.02.012","article-title":"Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia\/cachexia","volume":"12","author":"Chasen","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13277-013-1043-1","article-title":"Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model","volume":"35","author":"Chen","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0167-8140(97)01921-X","article-title":"Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy","volume":"43","author":"Chen","year":"1997","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JCO.1990.8.1.9","article-title":"Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer","volume":"8","author":"Chlebowski","year":"1990","journal-title":"J. Clin. Oncol."},{"issue":"Pt (1)","key":"10.1016\/j.critrevonc.2018.05.006_bib0250","first-page":"E50","article-title":"Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation","volume":"263","author":"Choo","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0255","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2004.07.697","article-title":"Accuracy of survival prediction by palliative radiation oncologists","volume":"61","author":"Chow","year":"2005","journal-title":"Int. J. Radiat. Oncol.*Biol.*Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0260","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00520-008-0486-1","article-title":"A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital","volume":"17","author":"Churm","year":"2009","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0265","first-page":"87","article-title":"The need for standardized assessment of muscle quality in skeletal muscle function deficit and other aging-related muscle dysfunctions: a symposium report","author":"Correa-de-Araujo","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0270","first-page":"42","article-title":"Enteral versus parenteral nutrition in cancer patients: evidences and controversies","volume":"5","author":"Cotogni","year":"2016","journal-title":"Ann. Palliat. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MPH.0b013e3181864a5e","article-title":"The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer\/treatment-related cachexia","volume":"30","author":"Couluris","year":"2008","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"28","key":"10.1016\/j.critrevonc.2018.05.006_bib0280","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","article-title":"Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","volume":"25","author":"Courneya","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","article-title":"The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis","volume":"37","author":"Cowley","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-011-0039-1","article-title":"The orally active melanocortin-4 receptor antagonist BL-6020\/979: a promising candidate for the treatment of cancer cachexia","volume":"2","author":"Dallmann","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0300","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpainsymman.2011.03.007","article-title":"A phase II dose titration study of thalidomide for cancer-associated anorexia","volume":"43","author":"Davis","year":"2012","journal-title":"J. Pain Symptom Manage"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib0305","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Del Fabbro","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib0310","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(89)90353-2","article-title":"Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group","volume":"25","author":"Della Cuna","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib0315","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00520-004-0615-4","article-title":"Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss","volume":"12","author":"Deutsch","year":"2004","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0320","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clnu.2011.05.008","article-title":"Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food","volume":"30","author":"Deutz","year":"2011","journal-title":"Clin. Nutr. (Edinb., Scotl.)"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib0325","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/cncr.28619","article-title":"Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer","volume":"120","author":"Dev","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0330","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0340","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.clnu.2007.07.004","article-title":"Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy","volume":"26","author":"Dillon","year":"2007","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0350","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0355","doi-asserted-by":"crossref","first-page":"601434","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0360","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nut.2011.11.009","article-title":"An analytic appraisal of nutrition screening tools supported by original data with particular reference to age","volume":"28","author":"Elia","year":"2012","journal-title":"Nutrition"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0365","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ejrad.2016.03.001","article-title":"Muscle analysis using pQCT, DXA and MRI","volume":"85","author":"Erlandson","year":"2016","journal-title":"Eur. J. Radiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol--a new facility for the measurement of health-related quality of life","volume":"16","author":"EuroQol","year":"1990","journal-title":"Health Policy"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0375","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"issue":"Pt. (1)","key":"10.1016\/j.critrevonc.2018.05.006_bib0380","first-page":"R181","article-title":"LPS-induced anorexia in leptin-deficient (ob\/ob) and leptin receptor-deficient (db\/db) mice","volume":"273","author":"Faggioni","year":"1997","journal-title":"Am. J. Physiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0385","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0390","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0395","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0400","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/PL00012351","article-title":"Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia","volume":"23","author":"Fearon","year":"1999","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0405","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0410","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"21","key":"10.1016\/j.critrevonc.2018.05.006_bib0415","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"5-6","key":"10.1016\/j.critrevonc.2018.05.006_bib0420","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2010.11.011","article-title":"Identification of serum proteins involved in pancreatic cancer cachexia","volume":"88","author":"Felix","year":"2011","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0425","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1673.1999.433665.x","article-title":"Validation of a malnutrition screening tool for patients receiving radiotherapy","volume":"43","author":"Ferguson","year":"1999","journal-title":"Australas. Radiol."},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2018.05.006_bib0430","first-page":"15","article-title":"Development of a quality of life index for patients with cancer","volume":"17","author":"Ferrans","year":"1990","journal-title":"Oncol. Nurs. Forum"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0435","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/nur.4770150106","article-title":"Psychometric assessment of the quality of life index","volume":"15","author":"Ferrans","year":"1992","journal-title":"Res. Nurs. Health"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nut.2012.05.005","article-title":"Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in elderly and clinical populations","volume":"29","author":"Fitschen","year":"2013","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11136-013-0456-z","article-title":"The functional living index-cancer is a reliable and valid instrument in Chinese cancer patients","volume":"23","author":"Fong","year":"2014","journal-title":"Qual. Life Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0450","first-page":"3349","article-title":"Thalidomide and its analogues inhibit lipopolysaccharide-mediated iinduction of cyclooxygenase-2","volume":"7","author":"Fujita","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0455","doi-asserted-by":"crossref","first-page":"e113259","DOI":"10.1371\/journal.pone.0113259","article-title":"Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"issue":"Pt (2)","key":"10.1016\/j.critrevonc.2018.05.006_bib0460","first-page":"E249","article-title":"Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass","volume":"275","author":"Gallagher","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0465","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.23367","article-title":"The endocannabinoid system: role in energy regulation","volume":"58","author":"Gamage","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0470","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl. (18)","key":"10.1016\/j.critrevonc.2018.05.006_bib0475","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1200\/jco.2007.25.18_suppl.9133","article-title":"A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia","volume":"25","author":"Garcia","year":"2007","journal-title":"J. Clin. Oncol. (Meet. Abstr.)"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0480","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","article-title":"Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials","volume":"16","author":"Garcia","year":"2015","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17040537","article-title":"Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics","volume":"17","author":"Garc\u00eda-Cort\u00e9s","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0490","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lungcan.2011.05.009","article-title":"Mini nutritional assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis","volume":"74","author":"Gioulbasanis","year":"2011","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0495","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdq440","article-title":"Baseline nutritional evaluation in metastatic lung cancer patients: mini nutritional assessment versus weight loss history","volume":"22","author":"Gioulbasanis","year":"2011","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0500","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.1995.13.11.2856","article-title":"Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial","volume":"13","author":"Goldberg","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0505","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0510","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rpor.2015.03.001","article-title":"Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy","volume":"20","author":"Gorenc","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0515","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: molecular mechanisms","volume":"4","author":"Gould","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0520","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nut.2005.06.003","article-title":"Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy","volume":"22","author":"Gramignano","year":"2006","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0525","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00520-013-2081-3","article-title":"Phase I\/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy","volume":"22","author":"Greig","year":"2014","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0530","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol Behav."},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0535","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI118653","article-title":"Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters","volume":"97","author":"Grunfeld","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"Pt (1)","key":"10.1016\/j.critrevonc.2018.05.006_bib0540","first-page":"S59","article-title":"Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation","volume":"54","author":"Guigoz","year":"1996","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0545","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.172.1.391","article-title":"Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin\/tumor necrosis factor synthesis at separate points in the signaling pathway","volume":"172","author":"Han","year":"1990","journal-title":"J. Exp. Med."},{"issue":"Suppl. (2)","key":"10.1016\/j.critrevonc.2018.05.006_bib0550","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1002\/dmrr.249","article-title":"The mode of action of thiazolidinediones","volume":"18","author":"Hauner","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0555","first-page":"2359","article-title":"Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients","volume":"58","author":"Hirai","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0560","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2015-3785","article-title":"Serum PTHrP predicts weight loss in cancer patients independent of hypercalcemia, inflammation, and tumor burden","volume":"101","author":"Hong","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0565","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13539-014-0142-1","article-title":"Psychosocial impact of cancer cachexia","volume":"5","author":"Hopkinson","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0570","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpainsymman.2005.09.005","article-title":"Helping patients with advanced cancer live with concerns about eating: a challenge for palliative care professionals","volume":"31","author":"Hopkinson","year":"2006","journal-title":"J. Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0575","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jpainsymman.2010.02.015","volume":"40","author":"Hopkinson","year":"2010","journal-title":"J. Pain Symptom Manage."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0580","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2648.2006.03818.x","article-title":"Exploring the experience of weight loss in people with advanced cancer","volume":"54","author":"Hopkinson","year":"2006","journal-title":"J. Adv. Nurs."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0585","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1079\/BJN20051412","article-title":"Change of the growth hormone-insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status","volume":"93","author":"Huang","year":"2005","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib0590","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1089\/jpm.2010.0413","article-title":"Family caregivers and palliative care: current status and agenda for the future","volume":"14","author":"Hudson","year":"2011","journal-title":"J. Palliat. Med."},{"issue":"Pt (3)","key":"10.1016\/j.critrevonc.2018.05.006_bib0595","first-page":"221","article-title":"The Nottingham Health Profile: subjective health status and medical consultations","volume":"15","author":"Hunt","year":"1981","journal-title":"Soc. Sci. Med. A"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0600","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ajcn\/84.5.1163","article-title":"Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy","volume":"84","author":"Hutton","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0605","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","article-title":"Proceedings: causes of death in cancer patients","volume":"33","author":"Inagaki","year":"1974","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0610","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bjc.6601962","article-title":"Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area","volume":"91","author":"Isenring","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2012.02.001","article-title":"Clinical nutrition, body composition and oncology: a critical literature review of the synergies","volume":"84","author":"Jacquelin-Ravel","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0620","first-page":"3084","article-title":"Interleukin 1 alpha increases serum leptin concentrations in humans","volume":"82","author":"Janik","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0625","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0630","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0635","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00520-005-0787-6","article-title":"Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Treatment Group","volume":"13","author":"Jatoi","year":"2005","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0640","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0645","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0773.1986.tb00080.x","article-title":"Further studies on the cardiomegaly induced by beta-adrenoceptor agonists","volume":"58","author":"Jeppsson","year":"1986","journal-title":"Acta Pharmacol. Toxicol. (Copenh.)"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0650","series-title":"Guide for Anthropometric Measurements of Canadian Adults","author":"Jett\u00e9","year":"1983"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0655","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1749-6632.2002.tb04674.x","article-title":"Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells","volume":"973","author":"Jin","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0660","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/diabetes.50.11.2438","article-title":"Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats","volume":"50","author":"Kamegai","year":"2001","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib0665","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/1097-0142(19900615)65:12<2657::AID-CNCR2820651210>3.0.CO;2-S","article-title":"A controlled trial of cyproheptadine in cancer patients with anorexia and\/or cachexia","volume":"65","author":"Kardinal","year":"1990","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.critrevonc.2018.05.006_bib0670","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","article-title":"Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity","volume":"276","author":"Keifer","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0675","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1477-7819-8-85","article-title":"The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer","author":"Kemik","year":"2010","journal-title":"World J. Surg. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2018.05.006_bib0680","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3748\/wjg.14.3633","article-title":"Adipokines and ghrelin in gastric cancer cachexia","volume":"14","author":"Kerem","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0685","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3346\/jkms.2012.27.2.128","article-title":"Pathophysiological role of hormones and cytokines in cancer cachexia","volume":"27","author":"Kim","year":"2012","journal-title":"J. Korean Med. Sci."},{"issue":"7516","key":"10.1016\/j.critrevonc.2018.05.006_bib0690","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0695","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1152\/japplphysiol.00873.2006","article-title":"Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol","volume":"102","author":"Kline","year":"2007","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0700","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0705","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1994.12.6.1113","article-title":"Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B","volume":"12","author":"Kosty","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0710","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr. J."},{"issue":"18","key":"10.1016\/j.critrevonc.2018.05.006_bib0715","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2007.07.013","article-title":"Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients","volume":"40","author":"Krzystek-Korpacka","year":"2007","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0720","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.NCC.0000290818.45066.00","article-title":"Critical evaluation of nutrition screening tools recommended for oncology patients","volume":"30","author":"Kubrak","year":"2007","journal-title":"Cancer Nurs."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0725","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-009-9568-x","article-title":"The functional living index-cancer: estimating its reliability based on clinical trial data","volume":"19","author":"Laenen","year":"2010","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0730","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hed.20662","article-title":"Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract","volume":"30","author":"Lai","year":"2008","journal-title":"Head Neck"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2018.05.006_bib0735","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0899-9007(01)80001-0","article-title":"Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia","volume":"17","author":"Langer","year":"2001","journal-title":"Nutrition"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0740","series-title":"Stress, Appraisal, and Coping","author":"Lazarus","year":"1984"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0745","doi-asserted-by":"crossref","first-page":"636","DOI":"10.20452\/pamw.510","article-title":"Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis","volume":"118","author":"Lesniak","year":"2008","journal-title":"Pol. Arch. Med. Wewn"},{"issue":"90180","key":"10.1016\/j.critrevonc.2018.05.006_bib0750","doi-asserted-by":"crossref","first-page":"18546","DOI":"10.1200\/jco.2006.24.18_suppl.18546","article-title":"A phase III randomized study comparing the effects of Oxandrolone (Ox) and Megestrol acetate (Meg) on weight (wt), lean body mass (LBM) and quality of life (QOL) in solid tumor patients (pts) receiving chemotherapy (chemo)","volume":"24","author":"Lesser","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0755","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ejcn.2013.121","article-title":"Influence of additional criteria from a definition of cachexia on its prevalence--good or bad thing?","volume":"67","author":"Letilovic","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0760","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-12-6","article-title":"Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure - is there only one cachexia?","volume":"12","author":"Letilovic","year":"2013","journal-title":"Nutr. J."},{"issue":"18","key":"10.1016\/j.critrevonc.2018.05.006_bib0765","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","article-title":"Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0770","article-title":"Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of life-brief among lung cancer patients","author":"Lin","year":"2015","journal-title":"J. Health Psychol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0775","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/SPC.0000000000000170","article-title":"The therapeutic potential of exercise to treat cachexia","volume":"9","author":"Lira","year":"2015","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0780","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0959-8049(96)00136-0","article-title":"Is there a role for melatonin in the treatment of neoplastic cachexia?","volume":"32a","author":"Lissoni","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib0785","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0790","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.lungcan.2007.09.015","article-title":"Symptoms and problems with functioning among women and men with inoperable lung cancer--a longitudinal study","volume":"60","author":"Lovgren","year":"2008","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0795","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.20160","article-title":"Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function","volume":"100","author":"Lundholm","year":"2004","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0800","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.critrevonc.2018.05.006_bib0805","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1517\/14656566.2012.734297","article-title":"Current pharmacotherapy options for cancer anorexia and cachexia","volume":"13","author":"Maccio","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0810","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life","volume":"124","author":"Maccio","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0815","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0895-4356(96)00316-2","article-title":"Measuring the accuracy of prognostic judgments in oncology","volume":"50","author":"Mackillop","year":"1997","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0820","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/SPC.0000000000000010","article-title":"Immunological and hormonal effects of exercise: implications for cancer cachexia","volume":"7","author":"Maddocks","year":"2013","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0825","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0b013e32834bdde3","article-title":"Improving muscle mass and function in cachexia: non-drug approaches","volume":"5","author":"Maddocks","year":"2011","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0830","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevOncog.v17.i3.80","article-title":"Multitargeted treatment of cancer cachexia","volume":"17","author":"Madeddu","year":"2012","journal-title":"Crit. Rev. Oncog."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0835","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/14656560902960162","article-title":"Medroxyprogesterone acetate in the management of cancer cachexia","volume":"10","author":"Madeddu","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"issue":"25","key":"10.1016\/j.critrevonc.2018.05.006_bib0840","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","article-title":"Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care","volume":"23","author":"Maltoni","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0845","first-page":"292","article-title":"Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia","volume":"14","author":"Mantovani","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0850","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02592554","article-title":"Megestrol acetate in neoplastic anorexia\/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy","volume":"25","author":"Mantovani","year":"1995","journal-title":"Int. J. Clin. Lab Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0855","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-200161040-00004","article-title":"Managing cancer-related anorexia\/cachexia","volume":"61","author":"Mantovani","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0860","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","article-title":"Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia","volume":"88","author":"Mantovani","year":"2010","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0865","first-page":"1432","article-title":"Role of the central melanocortin system in cachexia","volume":"61","author":"Marks","year":"2001","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0870","first-page":"764","article-title":"Megestrol acetate therapy in geriatric patients: case reviews and associated deep vein thrombosis","volume":"18","author":"Marshall","year":"2003","journal-title":"Consult Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0875","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.critrevonc.2018.05.006_bib0880","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1200\/JCO.2009.27.1916","article-title":"Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction","volume":"28","author":"Martin","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib0885","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/1467-9566.ep10933316","article-title":"Reneotiating identity: cancer narratives","volume":"17","author":"Mathieson","year":"1995","journal-title":"Sociol. Health Illn."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0890","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jpainsymman.2008.06.005","article-title":"Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life","volume":"37","author":"Mazzotta","year":"2009","journal-title":"J. Pain Symptom Manage."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2018.05.006_bib0895","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(94)90229-1","article-title":"Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations","volume":"265","author":"McCarthy","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0900","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/082585970402000205","article-title":"Family responses to declining intake and weight loss in a terminally ill relative. Part 1: fighting back","volume":"20","author":"McClement","year":"2004","journal-title":"J. Palliat. Care"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0905","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1523-5394.2002.102007.x","article-title":"Reflections on nutritional issues associated with cancer therapy","volume":"10","author":"McGrath","year":"2002","journal-title":"Cancer Pract."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0910","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2018.05.006_bib0915","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","article-title":"A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss","volume":"79","author":"McMillan","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib0920","first-page":"60","article-title":"Pentoxifylline treatment in patients with cancer cachexia: a double-blind, randomized, placebo-controlled clinical trial","author":"Mehrzad","year":"2016","journal-title":"Adv. Biomed. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0925","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/01635581.2015.976318","article-title":"Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options","volume":"67","author":"Mondello","year":"2015","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0930","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/1471-2407-14-828","article-title":"Emerging markers of cachexia predict survival in cancer patients","volume":"14","author":"Mondello","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib0935","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-7525-1-19","article-title":"Quality of life in lung cancer patients: does socioeconomic status matter?","volume":"1","author":"Montazeri","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0940","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14728214.2012.652946","article-title":"Editorial update on emerging drugs for cancer cachexia","volume":"17","author":"Murphy","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0945","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cncr.25709","article-title":"Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy","volume":"117","author":"Murphy","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0950","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: new insights into an old problem","volume":"42","author":"Muscaritoli","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib0955","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/annonc\/mdw420","article-title":"Perspectives of health care professionals on cancer cachexia: results from three global surveys","volume":"27","author":"Muscaritoli","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib0960","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib0965","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00520-015-2625-9","article-title":"Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines","volume":"23","author":"Naing","year":"2015","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib0970","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/SPC.0000000000000238","article-title":"Does physical exercise improve quality of life of advanced cancer patients?","volume":"10","author":"Navigante","year":"2016","journal-title":"Curr. Opin. Supportive Palliat. Care"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib0975","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial","volume":"89","author":"Neary","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15\u201316","key":"10.1016\/j.critrevonc.2018.05.006_bib0980","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1365-2702.2010.03667.x","article-title":"Comparison of five malnutrition screening tools in one hospital inpatient sample","volume":"20","author":"Neelemaat","year":"2011","journal-title":"J. Clin. Nurs."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib0985","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biopha.2013.08.005","article-title":"Malnutrition, anorexia and cachexia in cancer patients: a mini-review on pathogenesis and treatment","volume":"67","author":"Nicolini","year":"2013","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib0990","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2012.06.020","article-title":"Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysis","volume":"46","author":"Oberholzer","year":"2013","journal-title":"J. Pain Symptom Manage."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib0995","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1634\/theoncologist.2011-0133","article-title":"Physical exercise for cancer patients with advanced disease: a randomized controlled trial","volume":"16","author":"Oldervoll","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib1000","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12885-016-2424-9","article-title":"Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats","volume":"16","author":"Oliveira","year":"2016","journal-title":"BMC Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2018.05.006_bib1005","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0899-9007(96)90011-8","article-title":"Definition of standardized nutritional assessment and interventional pathways in oncology","volume":"12","author":"Ottery","year":"1996","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/13548506.2010.482139","article-title":"Psychometric properties of the World Health Organization Quality of Life Questionnaire (WHOQOL-100) in Portuguese patients with sarcoma","volume":"15","author":"Paredes","year":"2010","journal-title":"Psychol. Health Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00520-005-0889-1","article-title":"EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units","volume":"14","author":"Park","year":"2006","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","article-title":"Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome","volume":"27","author":"Pascual Lopez","year":"2004","journal-title":"J. Pain Symptom Manage."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib1030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PPO.0000000000000100","article-title":"Cancer cachexia, recent advances, and future directions","volume":"21","author":"Penet","year":"2015","journal-title":"Cancer J."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1035","first-page":"255","article-title":"[Megestrol in the treatment of AIDS associated cachexia. Evaluation by bioelectric impedance analysis of body composition]","volume":"15","author":"Perez De Oteyza","year":"1998","journal-title":"An. Med. Interna"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1040","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","article-title":"The anti-inflammatory effect of exercise","volume":"98","author":"Petersen","year":"2005","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jnutbio.2004.02.002","article-title":"Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats","volume":"15","author":"Pinto","year":"2004","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib1055","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib1060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SPC.0000000000000087","article-title":"Psychosocial, educational and communicative interventions for patients with cachexia and their family carers","volume":"8","author":"Reid","year":"2014","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijnurstu.2008.10.012","article-title":"The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members","volume":"46","author":"Reid","year":"2009","journal-title":"Int. J. Nurs. Stud."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0269216312441382","article-title":"Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review","volume":"27","author":"Reid","year":"2013","journal-title":"Palliat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1080","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jan.12268","article-title":"Evaluation of a psychoeducational intervention for patients with advanced cancer who have cachexia and their lay carers (EPACaCC): study protocol","volume":"70","author":"Reid","year":"2014","journal-title":"J. Adv. Nurs."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib1085","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40262-015-0363-2","article-title":"Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome","volume":"55","author":"Reuter","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib1090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1016670403148","article-title":"Re-validation and shortening of the Functional Assessment of Anorexia\/Cachexia Therapy (FAACT) questionnaire","volume":"9","author":"Ribaudo","year":"2000","journal-title":"Qual. Life Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0269216311418709","article-title":"A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project","volume":"26","author":"Ries","year":"2012","journal-title":"Palliat. Med."},{"issue":"Suppl. 15","key":"10.1016\/j.critrevonc.2018.05.006_bib1100","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1200\/jco.2010.28.15_suppl.7622","article-title":"Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): results of a phase II randomized, double-blind safety and efficacy trial","volume":"28","author":"Rigas","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SLA.0b013e31819a4789","article-title":"Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial","volume":"249","author":"Ryan","year":"2009","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00520-014-2484-9","article-title":"Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia","volume":"23","author":"Salsman","year":"2015","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1115","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clnu.2014.03.006","article-title":"Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial","volume":"33","author":"Sanchez-Lara","year":"2014","journal-title":"Clin. Nutr."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1120","first-page":"135","article-title":"Development of a comprehensive quality of life measurement tool: CARES","volume":"4","author":"Schag","year":"1990","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1125","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/1097-0142(19910915)68:6<1406::AID-CNCR2820680638>3.0.CO;2-2","article-title":"CAncer rehabilitation evaluation system--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument","volume":"68","author":"Schag","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3810\/psm.2009.10.1730","article-title":"Effects of a 12-month randomized controlled trial of aerobic or resistance exercise during and following cancer treatment in women","volume":"37","author":"Schwartz","year":"2009","journal-title":"Phys. Sportsmed."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ctrv.2008.03.003","article-title":"Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit?","volume":"34","author":"Senesse","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1145","first-page":"375","article-title":"[Significance of autopsy in patients with head and neck cancer]","volume":"91","author":"Sesterhenn","year":"2012","journal-title":"Laryngorhinootologie"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib1150","first-page":"774","article-title":"Increased plasma ghrelin level in lung cancer cachexia","volume":"9","author":"Shimizu","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/187153012802002910","article-title":"Cancer cachexia: molecular targets and pathways for diagnosis and drug intervention","volume":"12","author":"Shum","year":"2012","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1160","first-page":"973","article-title":"Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine","volume":"36","author":"Skipworth","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1165","first-page":"693","article-title":"Validation of quality of life index-cancer among korean patients with cancer","volume":"34","author":"So","year":"2004","journal-title":"Taehan Kanho Hakhoe Chi"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/SPC.0b013e328359b668","article-title":"Evidence base for multimodal therapy in cachexia","volume":"6","author":"Solheim","year":"2012","journal-title":"Curr. Opin. Support Palliat Care"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/0284186X.2012.724536","article-title":"Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review","volume":"52","author":"Solheim","year":"2013","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib1180","first-page":"212345","article-title":"Association of interleukin-8 with cachexia from patients with low-third gastric cancer","author":"Song","year":"2009","journal-title":"Comp. Funct. Genomics"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1185","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bjc.6603280","article-title":"The views and practice of oncologists towards nutritional support in patients receiving chemotherapy","volume":"95","author":"Spiro","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1008890401133","article-title":"The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview","volume":"7","author":"Sprangers","year":"1998","journal-title":"EORTC Qual. Life Study Group Qual. Life Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","article-title":"Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review","volume":"88","author":"Stene","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib1205","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1210\/jc.2005-0275","article-title":"A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment","volume":"90","author":"Storer","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MCO.0b013e3283025e27","article-title":"Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue","volume":"11","author":"Strasser","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib1220","article-title":"Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)","author":"Stukan","year":"2017","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib1225","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","article-title":"An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment Status","volume":"67","author":"Sun","year":"2015","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.critrevonc.2018.05.006_bib1230","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2147\/TCRM.S79374","article-title":"Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients","volume":"11","author":"Suno","year":"2015","journal-title":"Ther. Clin. Risk Manage."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00482-015-0092-3","article-title":"Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews","volume":"30","author":"Tafelski","year":"2016","journal-title":"Schmerz"},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib1240","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1210\/jcem.85.12.7167","article-title":"Ghrelin strongly stimulates growth hormone release in humans","volume":"85","author":"Takaya","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1245","first-page":"88","article-title":"Pancreatic cancer cachexia: a review of mechanisms and therapeutics","author":"Tan","year":"2014","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1250","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib1255","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0277-9536(98)00009-4","article-title":"(WHOQOL): development and general psychometric properties","volume":"46","author":"The World Health Organization Quality of Life Assessment","year":"1998","journal-title":"Soc. Sci. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1260","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Thoresen","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.critrevonc.2018.05.006_bib1265","first-page":"340","article-title":"Molecular pathways leading to cancer cachexia","volume":"20","author":"Tisdale","year":"2005","journal-title":"Physiology (Bethesda)"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib1270","first-page":"2353","article-title":"Purification and characterization of a tumor lipid-mobilizing factor","volume":"58","author":"Todorov","year":"1998","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcsm.12035","article-title":"A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy","volume":"7","author":"Toledo","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","article-title":"Formoterol in the treatment of experimental cancer cachexia: effects on heart function","volume":"5","author":"Toledo","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1285","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"Pt (3)","key":"10.1016\/j.critrevonc.2018.05.006_bib1290","first-page":"R613","article-title":"Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor","volume":"257","author":"Uehara","year":"1989","journal-title":"Am. J. Physiol."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.05.006_bib1295","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1017\/S0007114512004527","article-title":"Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks","volume":"109","author":"van der Meij","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib1300","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3945\/jn.110.121202","article-title":"Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment","volume":"140","author":"van der Meij","year":"2010","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1305","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcsm.12029","article-title":"Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients","volume":"6","author":"van Dijk","year":"2015","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1310","doi-asserted-by":"crossref","first-page":"e000097","DOI":"10.1136\/bmjgast-2016-000097","article-title":"Cachexia in cancer: what is in the definition?","volume":"3","author":"Vanhoutte","year":"2016","journal-title":"BMJ Gastroenterol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib1315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ejcn.2010.243","article-title":"Comparison of four nutritional screening tools to detect nutritional risk in hospitalized patients: a multicentre study","volume":"65","author":"Velasco","year":"2011","journal-title":"Eur. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1320","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients","volume":"21","author":"Wallengren","year":"2013","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1325","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","article-title":"The immediate causes of death in cancer","volume":"184","author":"Warren","year":"1932","journal-title":"Am. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","article-title":"Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways","volume":"143","author":"Waseem","year":"2008","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.critrevonc.2018.05.006_bib1335","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hed.21580","article-title":"Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid","volume":"33","author":"Weed","year":"2011","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1340","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000346446","article-title":"Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide","volume":"58","author":"Wen","year":"2012","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.05.006_bib1345","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/01635581.2015.1004728","article-title":"Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer","volume":"67","author":"Wesseltoft-Rao","year":"2015","journal-title":"Nutr Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1350","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/SPC.0000000000000168","article-title":"Patient-reported outcomes in cancer cachexia clinical trials","volume":"9","author":"Wheelwright","year":"2015","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"9","key":"10.1016\/j.critrevonc.2018.05.006_bib1355","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00520-013-1881-9","article-title":"A systematic review of health-related quality of life instruments in patients with cancer cachexia","volume":"21","author":"Wheelwright","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib1360","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpainsymman.2016.09.010","article-title":"Development of the EORTC QLQ-CAX24, a questionnaire for cancer patients with cachexia","volume":"53","author":"Wheelwright","year":"2017","journal-title":"J. Pain Symptom Manage."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.05.006_bib1365","doi-asserted-by":"crossref","first-page":"e0161407","DOI":"10.1371\/journal.pone.0161407","article-title":"A systematic review of predictions of survival in palliative care: how accurate are clinicians and who are the experts?","volume":"11","author":"White","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.05.006_bib1370","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/bjs.1800840214","article-title":"Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer","volume":"84","author":"Wigmore","year":"1997","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.05.006_bib1375","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2168.2000.01317.x","article-title":"Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor","volume":"87","author":"Wigmore","year":"2000","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.05.006_bib1380","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2354.2011.01255.x","article-title":"Poor tolerability of thalidomide in end-stage oesophageal cancer","volume":"20","author":"Wilkes","year":"2011","journal-title":"Eur. J. Cancer Care (Engl.)"},{"issue":"6410","key":"10.1016\/j.critrevonc.2018.05.006_bib1385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmj.288.6410.27","article-title":"Prednisolone as an appetite stimulant in patients with cancer","volume":"288","author":"Willox","year":"1984","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.05.006_bib1390","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1464-410X.2005.05403.x","article-title":"The assessment of patient life-expectancy: how accurate are urologists and oncologists?","volume":"95","author":"Wilson","year":"2005","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1395","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cncr.21690","article-title":"Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients","volume":"106","author":"Wolf","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.05.006_bib1400","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bjc.6602402","article-title":"NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle","volume":"92","author":"Wyke","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.05.006_bib1405","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/jpm.2012.0146","article-title":"The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study","volume":"15","author":"Yennurajalingam","year":"2012","journal-title":"J. Palliat. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.05.006_bib1410","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"New Engl. J. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817302731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817302731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T18:20:19Z","timestamp":1751653219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817302731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":282,"alternative-id":["S1040842817302731"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cachexia: Diagnosis, assessment, and treatment","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}